2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+))

C136H85N20Pt4S4+ — CID 158091546

About 2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+))

2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+)) (PubChem CID 158091546) has the molecular formula C136H85N20Pt4S4+ and a molecular weight of 2907.90 g/mol. Its IUPAC name is 2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+)).

Molecular Properties

• Compound Name: 2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+))
• PubChem CID: 158091546
• Molecular Formula: C136H85N20Pt4S4+
• Molecular Weight: 2907.90 g/mol
• Exact Mass: 2905.47
• IUPAC Name: 2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+))
• SMILES: C[n+]1cc[nH]c1-c1cccc2c3ccc(-c4nc5ccccc5s4)[c-]c3n(-c3[c-]c(-c4ccccn4)ccc3)c12.Cn1ccnc1-c1ccc2c(c1)c1ccc(-c3nc4ccccc4s3)[c-]c1n2-c1[c-]c(-c2ccccn2)ccc1.Cn1ccnc1-c1ccc2c3ccc(-c4nc5ccccc5s4)[c-]c3n(-c3[c-]c(-c4ccccn4)ccc3)c2c1.Cn1ccnc1-c1cccc2c1c1ccc(-c3nc4ccccc4s3)[c-]c1n2-c1[c-]c(-c2ccccn2)ccc1.[Pt+2].[Pt+2].[Pt+2].[Pt+2]
• InChI: InChI=1S/4C34H21N5S.4Pt/c1-38-19-18-36-33(38)27-11-7-10-26-25-16-15-23(34-37-29-13-2-3-14-31(29)40-34)21-30(25)39(32(26)27)24-9-6-8-22(20-24)28-12-4-5-17-35-28;1-38-19-18-36-33(38)26-10-7-13-29-32(26)25-16-15-23(34-37-28-12-2-3-14-31(28)40-34)21-30(25)39(29)24-9-6-8-22(20-24)27-11-4-5-17-35-27;1-38-18-17-36-33(38)23-13-15-30-27(20-23)26-14-12-24(34-37-29-10-2-3-11-32(29)40-34)21-31(26)39(30)25-8-6-7-22(19-25)28-9-4-5-16-35-28;1-38-18-17-36-33(38)23-12-14-26-27-15-13-24(34-37-29-10-2-3-11-32(29)40-34)21-31(27)39(30(26)20-23)25-8-6-7-22(19-25)28-9-4-5-16-35-28;;;;/h2*2-19H,1H3;2*2-18,20H,1H3;;;;/q4*-2;4*+2/p+1
• InChIKey: JTWSWZNUXSNABC-UHFFFAOYSA-O
• XLogP: 31.90
• TPSA: 195.97 Ų
• H-Bond Donors: 1
• H-Bond Acceptors: 22
• Rotatable Bonds: 16
• Heavy Atoms: 164
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2907.90
LogP ≤ 5	31.90
H-Bond Donors ≤ 5	1
H-Bond Acceptors ≤ 10	22

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+))?

The IUPAC name of 2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+)) (CID 158091546) is 2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+)).

What is the SMILES notation for 2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+))?

The canonical SMILES for 2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+)) is C[n+]1cc[nH]c1-c1cccc2c3ccc(-c4nc5ccccc5s4)[c-]c3n(-c3[c-]c(-c4ccccn4)ccc3)c12.Cn1ccnc1-c1ccc2c(c1)c1ccc(-c3nc4ccccc4s3)[c-]c1n2-c1[c-]c(-c2ccccn2)ccc1.Cn1ccnc1-c1ccc2c3ccc(-c4nc5ccccc5s4)[c-]c3n(-c3[c-]c(-c4ccccn4)ccc3)c2c1.Cn1ccnc1-c1cccc2c1c1ccc(-c3nc4ccccc4s3)[c-]c1n2-c1[c-]c(-c2ccccn2)ccc1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].

What is the InChIKey of 2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+))?

The InChIKey is JTWSWZNUXSNABC-UHFFFAOYSA-O. The full InChI is InChI=1S/4C34H21N5S.4Pt/c1-38-19-18-36-33(38)27-11-7-10-26-25-16-15-23(34-37-29-13-2-3-14-31(29)40-34)21-30(25)39(32(26)27)24-9-6-8-22(20-24)28-12-4-5-17-35-28;1-38-19-18-36-33(38)26-10-7-13-29-32(26)25-16-15-23(34-37-28-12-2-3-14-31(28)40-34)21-30(25)39(29)24-9-6-8-22(20-24)27-11-4-5-17-35-27;1-38-18-17-36-33(38)23-13-15-30-27(20-23)26-14-12-24(34-37-29-10-2-3-11-32(29)40-34)21-31(26)39(30)25-8-6-7-22(19-25)28-9-4-5-16-35-28;1-38-18-17-36-33(38)23-12-14-26-27-15-13-24(34-37-29-10-2-3-11-32(29)40-34)21-31(27)39(30(26)20-23)25-8-6-7-22(19-25)28-9-4-5-16-35-28;;;;/h2*2-19H,1H3;2*2-18,20H,1H3;;;;/q4*-2;4*+2/p+1.

What are the key properties of 2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+))?

2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+)) has a molecular weight of 2907.90 g/mol, XLogP of 31.90, 16 rotatable bonds, 1 hydrogen bond donors, and 22 hydrogen bond acceptors.

Where does this data come from?

All data for 2-[8-(3-methyl-1H-imidazol-3-ium-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[5-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[6-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;2-[7-(1-methylimidazol-2-yl)-9-(3-pyridin-2-ylbenzene-2-id-1-yl)-1H-carbazol-1-id-2-yl]-1,3-benzothiazole;tetrakis(platinum(2+)) is sourced from PubChem (CID 158091546), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).